MYOS RENS TECHNOLOGY INC. MYOS Income Statement

Myos rens technology inc. (MYOS)

Income statement / Quarterly

Mar'20	Dec'19	Sep'19	Jun'19	Mar'19	Dec'18	Sep'18	Jun'18	Mar'18	Dec'17	Sep'17	Jun'17	Mar'17	Dec'16	Sep'16	Jun'16	Mar'16	Dec'15	Sep'15	Jun'15	Mar'15	Dec'14	Sep'14	Jun'14	Mar'14	Dec'13	Sep'13	Jun'13	Mar'13	Dec'12	Sep'12	Jun'12	Mar'12	Dec'11	Sep'11	Jun'11	Mar'11	Sep'10	Jun'10
Net revenues
290	379	350	154	149	149	66	88	57	-	160	59	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net revenues
-	-	-	-	-	-	-	-	-	-	-	-	150	27	39	66	195	35	36	82	6	11	107	1,679	1,546	1,407	918	715	277	177	365	343	24	43	55	0	0	0	0
Cost of revenues
158	81	174	81	61	96	59	62	31	64	65	44	135	27	30	49	213	348	396	31	5	138	232	645	405	648	428	318	126	207	354	292	8	23	26	0	0	0	-
Gross profit
132	298	176	73	88	53	7	26	26	93	95	15	15	0	9	17	-18	-313	-360	51	1	-127	-125	1,034	1,141	759	490	397	150	-29	11	51	15	19	29	0	0	0	-
Operating expenses:
Selling, marketing and research
202	325	339	337	275	137	128	235	394	223	91	208	300	-	97	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Selling and marketing
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	527	161	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Research & development
-	-	-	-	-	-	-	-	-	-	-	-	-	-	4	5	-	-	231	214	189	254	365	295	434	-	113	107	-	-	-	-	-	-	-	-	-	-	-
Personnel and benefits
468	601	406	470	420	557	396	348	417	397	309	411	333	782	281	399	391	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Share-based compensation
-	-	-	-	-	-	-	-	-	-	-	-	-	-	38	129	97	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
General and administrative
315	550	342	432	356	533	392	477	427	553	452	505	504	384	391	395	446	-	-	-	-	-	-	-	1,130	-	1,159	1,275	-	992	1,058	593	439	916	1,405	613	1,711	2	20
Selling, general and administrative
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	645	735	1,288	-	1,637	1,685	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization of acquired intangibles
-	-	-	-	-	-	-	-	-	-	-	-	-	-	53	53	52	52	53	53	52	-	50	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Bad debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Amortization
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	50	0	-	0	-	-	-	-	-	-	-	-	-	-	-	-
Loss on asset impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	44	0	0	0	0	-	0	5	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Loss on asset impairment
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-
Total operating expenses
985	1,476	1,087	1,239	1,051	1,227	916	1,060	1,238	1,173	852	1,124	1,137	752	864	1,508	1,191	981	929	1,002	1,529	1,477	2,052	2,035	1,564	2,167	1,272	1,382	1,242	-	-	-	-	-	-	-	-	-	-
Operating loss
-853	-1,178	-911	-1,166	-963	-1,174	-909	-1,034	-1,212	-1,080	-757	-1,109	-1,122	-752	-855	-1,491	-1,209	-1,294	-1,289	-951	-1,528	-1,604	-2,177	-1,001	-423	-1,407	-782	-985	-1,092	-1,021	-1,047	-542	-423	-896	-1,375	-613	-1,711	-2	-20
Other expense:
Interest expense
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-0	0	778	23	11	5	5	2	0	0
Other expense, net
-13	-	-	-9	-12	-	-	0	-1	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-	-	-	-	-	-	-	-	-	-
Other (expense) income
-	-	-	-	-	-	-	-	-	-1	5	3	5	-	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Interest income
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1	-	-	0	0	1	1	0	1	1	1	2	5	0	0	-	0	-	-	-	-
Interest expense
-	-	10	-	-	-	2	-	-	-	1	-	-	1	11	12	11	4	5	6	0	-	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Value of warrants in excess of the amount of additional paid-in capital received in the related private placement of restricted common stock
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	-2,373	-32	0	0	0	0
Change in fair value of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-36	229	-227	18	-	-3,270	1,448	-	0	-
Change in fair value of warrants
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	460	-	0
Impairment charge - intellectual property
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	2,662	0	0	0	-	-
Amortization of deferred financing costs
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	35	34	-471	0	482	0	-	-
Gain on forgiveness of debt
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	0	0	0	0
Total other expense
-	-	-	-	-	-	-	-	-	-	-	-	-	0	-11	-12	-11	-4	-4	-6	0	-	-	-	1	0	1	1	1	3	235	-1,041	-75	-1,835	3,233	-1,936	-462	-0	-0
Loss before income taxes
-	-	-921	-1,175	-	-	-911	-1,034	-	-	-	-1,106	-	-	-	-1,503	-1,220	-1,298	-1,293	-957	-1,528	-1,608	-2,177	-1,000	-422	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Income tax benefit
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	1	0	1	-748	0	0	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss
-866	-1,187	-921	-1,175	-975	-65	-911	-1,034	-1,213	-1,082	-753	-1,106	-1,117	-752	-866	-1,503	-1,220	-1,298	-1,294	-957	-1,529	-860	-2,177	-1,000	-422	-1,407	-781	-984	-1,090	-1,018	-812	-1,584	-498	-	-	-	-	-	-
Deemed dividend resulting from warrant modification
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	-225	-	-	0	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share attributable to common shareholders:
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-1,294	-1,182	-	-	-2,177	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-
Net loss per share attributable to common shareholders:
Weighted average number of common shares outstanding, basic and diluted
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	53,454	49,000,000	49,000
Basic and diluted
-0.09	-0.10	-0.10	-0.13	-0.13	0.00	-0.12	-0.14	-0.19	-0.17	-0.13	-0.19	-0.20	-0.12	-0.17	-0.30	-0.31	-0.38	-0.39	-0.37	-0.50	-0.31	-0.75	-0.34	-0.16	-0.67	-0.35	-0.44	-0.47	-2.09	-0.01	-0.02	-0.01	-0.04	0.03	-0.04	-0.04	0.00	0.00
Weighted average number of common shares outstanding:
Net income (loss)
-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	1,857	-2,549	-2,173	-2	-20
Basic and diluted
9,717	9,200	9,173	9,170	7,669	7,329	7,473	7,249	6,504	6,184	5,844	5,844	5,627	-9,040	5	5,057	3,997	-6,478	3,306	3,182	3	5,614	2,886	2,909	2	4,336	2,218	2	2,295	-250,467	106,387	79,944	71,495	-	65,476	61,317	-	-	-